Chronic Fluoxetine Administration during Different Postnatal Development Stages Leads to Stage Dependent Changes of Glial Fibrillary Acidic Protein Expression in Rat Brain

References (68)

1. 1 Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression∗∗See accompanying Editorial, in this issue. [DOI]
2. 2 Early-Life Blockade of the 5-HT Transporter Alters Emotional Behavior in Adult Mice [DOI]
3. 3 Alterations induced by gestational stress in brain morphology and behaviour of the offspring [DOI]
4. 4 Cellular changes in the postmortem hippocampus in major depression [DOI]
5. 5 Glial Loss in the Prefrontal Cortex Is Sufficient to Induce Depressive-like Behaviors [DOI]
6. 6 Astrocyte heterogeneity: an underappreciated topic in neurobiology [DOI]
7. 7 Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for Difficult-to-Treat depression [DOI]
8. 8 Modern views on an ancient chemical: serotonin effects on cell proliferation, maturation, and apoptosis [DOI]
9. 9 An immunohistochemical study of serotonin neuron development in the rat: Ascending pathways and terminal fields [DOI]
10. 10 Regulation of Adult Neurogenesis by Antidepressant Treatment [DOI]
11. 11 Astroglial Plasticity in the Hippocampus is Affected by Chronic Psychosocial Stress and Concomitant Fluoxetine Treatment [DOI]
12. 12 Structural and quantitative analysis of astrocytes in the mouse hippocampus [DOI]
13. 13 The serotonergic and noradrenergic systems of the hippocampus: their interactions and the effects of antidepressant treatments [DOI]
14. 14 Serotonergic modulation of the limbic system [DOI]
15. 15 Inhibition of Serotonin But Not Norepinephrine Transport during Development Produces Delayed, Persistent Perturbations of Emotional Behaviors in Mice [DOI]
16. 16 Cellular localization of the 5-HT receptor in primate brain neurons and glial cells [DOI]
17. 17 Glial fibrillary acidic protein mRNA levels in the cingulate cortex of individuals with depression, bipolar disorder and schizophrenia [DOI]
18. 18 Immunohistochemical Localization of Phosphorylated Glial Fibrillary Acidic Protein in the Prefrontal Cortex and Hippocampus from Patients with Schizophrenia, Bipolar Disorder, and Depression [DOI]
19. 19 Long-lasting behavioural and molecular alterations induced by early postnatal fluoxetine exposure are restored by chronic fluoxetine treatment in adult mice [DOI]
20. 20 Brain-derived neurotrophic factor (BDNF) infusion restored astrocytic plasticity in the hippocampus of a rat model of depression [DOI]
21. 21 Profiling of behavioral changes and hippocampal gene expression in mice chronically treated with the SSRI paroxetine [DOI]
22. 22 Serotonin and Drug-Induced Therapeutic Responses in Major Depression, Obsessive–Compulsive and Panic Disorders [DOI]
23. 23 Synchronized overproduction of neurotransmitter receptors in diverse regions of the primate cerebral cortex. [DOI]
24. 24 Age-associated changes in the densities of presynaptic monoamine transporters in different regions of the rat brain from early juvenile life to late adulthood [DOI]
25. 25 Early Methylphenidate Administration to Young Rats Causes a Persistent Reduction in the Density of Striatal Dopamine Transporters [DOI]
26. 26 Glial fibrillary acidic protein is reduced in cerebellum of subjects with major depression, but not schizophrenia [DOI]
27. 27 Long-term effects of early life deprivation on brain glia in Fischer rats [DOI]
28. 28 Up-Regulation of 5-HT2B Receptor Density and Receptor-Mediated Glycogenolysis in Mouse Astrocytes by Long-Term Fluoxetine Administration [DOI]
29. 29 Chronic antidepressant treatments increase basic fibroblast growth factor and fibroblast growth factor-binding protein in neurons [DOI]
30. 30 Role of Signal Transducer and Activator of Transcription-3 in Up-Regulation of GFAP After Epilepsy [DOI]
31. 31 Methylphenidate normalizes elevated dopamine transporter densities in an animal model of the attention-deficit/hyperactivity disorder combined type, but not to the same extent in one of the attention-deficit/hyperactivity disorder inattentive type [DOI]
32. 32 Inflammation-like glial response in rat brain induced by prenatal PFOS exposure [DOI]
33. 33 Secretion of S100B, an astrocyte-derived neurotrophic protein, is stimulated by fluoxetine via a mechanism independent of serotonin [DOI]
34. 34 Glia mechanisms in mood regulation: a novel model of mood disorders [DOI]
35. 35 Fluoxetine increases the nitric oxide production via nuclear factor kappa B-mediated pathway in BV2 murine microglial cells [DOI]
36. 36 High-Affinity Uptake of Serotonin Into Immunocytochemically Identified Astrocytes [DOI]
37. 37 Distribution of the neurotrophins brain-derived neurotrophic factor, neurotrophin-3, and neurotrophin-4/5 in the postnatal rat brain: an immunocytochemical study [DOI]
38. 38 Persistently Increased Density of Serotonin Transporters in the Frontal Cortex of Rats Treated with Fluoxetine During Early Juvenile Life [DOI]
39. 39 Further evidence that fluoxetine interacts with a 5-HT2C receptor in glial cells [DOI]
40. 40 Neuronal cell death induced by antidepressants: lack of correlation with Egr-1, NF-κB and extracellular signal-regulated protein kinase activation [DOI]
41. 41 Serotonin Metabolism by Monoamine Oxidase in Rat Primary Astrocyte Cultures [DOI]
42. 42 Dopamine receptor pruning during the peripubertal period is not attenuated by NMDA receptor antagonism in rat [DOI]
43. 43 Characterization of STAT3-expressing cells in the postnatal rat brain [DOI]
44. 44 Neuron—glia interactions: effect of serotonin on the astroglial expression of GFAP and of its encoding message [DOI]
45. 45 Alterations of Glial Cells in the Mouse Hippocampus During Postnatal Development [DOI]
46. 46 Very early treatment with fluoxetine and reboxetine causing long-lasting change of the serotonin but not the noradrenaline transporter in the frontal cortex of rats [DOI]
47. 47 Developmental Expression of the Glial Fibrillary Acidic Protein mRNA in the Central Nervous System and in Cultured Astrocytes [DOI]
48. 48 Glial cells as targets and producers of neurotrophins [DOI]
49. 49 Transcriptional regulation of glial fibrillary acidic protein (GFAP)‐mRNA expression during postnatal development of mouse brain [DOI]
50. 50 Adrenergic receptor regulation of amino acid neurotransmitter uptake in astrocytes [DOI]
51. 51 Requirement of Hippocampal Neurogenesis for the Behavioral Effects of Antidepressants [DOI]
52. 52 Chronic Antidepressant Treatment Increases Neurogenesis in Adult Rat Hippocampus [DOI]
53. 53 Synaptic density in human frontal cortex — Developmental changes and effects of aging [DOI]
54. 54 Protoplasmic Astrocytes in CA1 Stratum Radiatum Occupy Separate Anatomical Domains [DOI]
55. 55 Localization of the glial fibrillary acidic protein in astrocytes by immunofluorescence [DOI]
56. 56 Astrocyte glutamate transport: Review of properties, regulation, and physiological functions [DOI]
57. 57 Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells [DOI]
58. 58 Cell Proliferation in Adult Hippocampus is Decreased by Inescapable Stress: Reversal by Fluoxetine Treatment [DOI]
59. 59 Reduced Glial Cell Density and Neuronal Size in the Anterior Cingulate Cortex in Major Depressive Disorder [DOI]
60. 60 Differential regulation of gliogenesis in the context of adult hippocampal neurogenesis in mice [DOI]
61. 61 Age-Dependent Reductions in the Level of Glial Fibrillary Acidic Protein in the Prefrontal Cortex in Major Depression [DOI]
62. 62 Fluoxetine regulates the expression of neurotrophic/growth factors and glucose metabolism in astrocytes [DOI]
63. 63 Astrocyte–neuron vulnerability to prenatal stress in the adult rat brain [DOI]
64. 64 Randomised controlled trials of selective serotonin reuptake inhibitors in treating depression in children and adolescents: A systematic review and meta-analysis [DOI]
65. 65 Antidepressants act on glial cells: SSRIs and serotonin elicit astrocyte calcium signaling in the mouse prefrontal cortex [DOI]
66. 66 Development of serotonergic neurons and their projections [DOI]
67. 67 Antidepressant imipramine induces human astrocytes to differentiate into cells with neuronal phenotype [DOI]
68. 68 Neuronal and Astroglial Responses to the Serotonin and Norepinephrine Neurotoxin: 1-Methyl-4-(2′-aminophenyl)-1,2,3,6-tetrahydropyridine [DOI]

Cited by 3

Showing 1 of 3 known citations — external sources report more than can currently be individually listed.

Related research

• Effect of Carbohydrate Type on Brain Composition and Senescence in Aging, Hyperinsulinemia-prone OBESE LA/Ntul//-cp Rats — shares topic coverage
• Fish Lipids Functionality in Health and Disease — shares topic coverage
• Screen Time and Its Impacts on Youth Health and Brain Development — shares topic coverage
• Fluoxetine, a Selective Serotonin Reuptake Inhibitor Overdose Resulting in a Central Retinal Vein Occlusion — shares topic coverage
• Antidepressant Activity of Nardostachys jatamansi Extract in Animal Models of Depression — shares topic coverage